Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
Summary: Novel strategies are needed to identify drug targets and treatments for the COVID-19 pandemic. The altered gene expression of virus-infected host cells provides an opportunity to specifically inhibit viral propagation via targeting the synthetic lethal and synthetic dosage lethal (SL/SDL) p...
Main Authors: | Lipika R. Pal, Kuoyuan Cheng, Nishanth Ulhas Nair, Laura Martin-Sancho, Sanju Sinha, Yuan Pu, Laura Riva, Xin Yin, Fiorella Schischlik, Joo Sang Lee, Sumit K. Chanda, Eytan Ruppin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-05-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S258900422200582X |
Similar Items
-
Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets
by: Kuoyuan Cheng, et al.
Published: (2021-11-01) -
Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages
by: Caroline Gravel, et al.
Published: (2021-11-01) -
CSV2018: The 2nd Symposium of the Canadian Society for Virology
by: Nathalie Grandvaux, et al.
Published: (2019-01-01) -
Host and microbiome features of secondary infections in lethal covid-19
by: Martin Zacharias, et al.
Published: (2022-09-01) -
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression
by: Sanju Sinha, et al.
Published: (2020-07-01)